SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5167)6/19/1998 2:21:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 9719
 
Rman:

Have been on semi-vacation the last 18 hours, and packing up for Tahoe. Can't comment in detail, unless I get some time in tonight. Be careful of PGNX..... great concepts with respect to chemokine receptors/accessory HIV receptors, but mixed with (IMO) very, very poorly conceived stuff.

If you're interested in the PCOP collaboration, as V1 and I were discussing yesterday, you undoubtedly get some of the best potential with AGPH/Alanex.

Have a good weekend, all! Rick



To: Rocketman who wrote (5167)6/19/1998 4:24:00 PM
From: Andreas Helke  Read Replies (1) | Respond to of 9719
 
While you are looking at cancer vaccines you could check Corixa - CRXA. They got cheap again after demonstrating a: that they can go up seriously on news and b: that news induced rallies don't stick.

What is remarkable about Corixa is that they can induce a T cell response with their vaccine technology.

techstocks.com

corixa.com

Andreas


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News